Skip to content

Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma

Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04424472
Enrollment
50
Registered
2020-06-11
Start date
2020-07-17
Completion date
2022-12-01
Last updated
2020-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Cell Carcinoma

Brief summary

The aim of this study is to determine the utility of renal ultrasonography (US) in the detection of abdominal recurrences after definitive therapy for renal cell carcinoma (RCC) and compare the detection rate to that of cross-sectional imaging.

Interventions

DIAGNOSTIC_TESTUltrasonography

Abdominal Ultrasonography

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

The sonographer for the additional ultrasound will be blinded as will be the blinded radiology who will compare the US to the most recent negative CT/MRI to determine if recurrence is visualized by US

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients must be 18 year of age or older. * Patients having undergone radical or partial nephrectomy for the indication of renal cell carcinoma. * Most recent imaging study must have been either computed tomography (CT) or magnetic resonance imaging (MRI).

Exclusion criteria

* Patients with pT4 disease (tumor invades beyond the Gerota fascia: including contiguous extension into the ipsilateral adrenal gland). * Patients with metastatic disease prior to time of surgery requiring systemic treatment. * Patients with another active cancer diagnosis requiring systemic treatment. * Patients with contrast allergies. * Patients with baseline chronic kidney disease (GFR \< 45 ml/min/1.73 m2).

Design outcomes

Primary

MeasureTime frameDescription
Utility of Renal Ultrasonography (US) in the detection of abdominal recurrences4 weeksRenal Cell Carcinoma (RCC) recurrence detection of ultrasonography in patients who have undergo definitive therapy for RCC compared to detection rate of cross-sectional imaging

Secondary

MeasureTime frameDescription
Radiation Burden5 yearsCompare the average radiation exposure over 5 years for patients on current standard of care imaging surveillance for RCC, which consists of both ultrasound and cross-sectional imaging, to that of patients who would only receive cross-section imaging surveillance for RCC. This would yield overall increase in radiation burden for patients with RCC

Countries

United States

Contacts

Primary ContactKatherine Glavin
kglavin@kumc.edu913-588-8721

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026